Connect Sign In
The addition of GAMT deficiency to the federal Recommended Uniform Screening Panel is an important milestone for ARUP medical directors and a Utah mom who say the change will improve lives.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated resources on testing for bariatric surgery, respiratory viruses, and alpha-1-antitrypsin deficiency.
A $3.6 million gift from the Miller family will enable University of Utah Health and ARUP to expand and refine testing for rare genetic disorders through the Utah NeoSeq Project.
In September, ARUP Consult, a free informative resource in laboratory testing, released new user experience (UX) upgrades and updated several topics, including acute lymphoblastic leukemia.
New research published in Blood sheds light on diagnosis, disease characteristics, and prognoses for inherited hematologic malignancies associated with DDX41 germline variants.
ARUP Consult, a free source of expert guidance in laboratory testing, offers valuable information on relevant topics from monkeypox to HLA testing and more.
ARUP medical directors and scientists will share their research and expertise in areas like lab stewardship, biochemical genetics, and neonatal drug testing at AACC’s 2022 annual meeting in Chicago.
Scientist Michael T. Pyne shares ARUP’s challenges and process of developing a next generation sequencing (NGS) test for HIV-1 antiretroviral drug resistance.
ARUP Consult, a free source of expert guidance in laboratory testing, has released new and updated resources on testing for immunobullous diseases, diabetes mellitus, and prostate cancer.
ARUP experts are to give six talks and poster presentations at the flagship annual meeting of the American Society for Microbiology (ASM) in Washington, D.C.
ARUP Consult, a free source of expert guidance in laboratory testing, has released new resources on newborn drug screening and noninvasive prenatal testing.
Noninvasive prenatal testing (NIPT) provides critical information to expectant parents. ARUP has updated its test offerings to include the most sensitive and specific alternatives available.
